Recent Updates
Recently added Catalysts
DBVT

DBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company Monthly information regarding the total number of voting rights and t...

Key Takeaway: Accessibility: Skip TopNav DBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company Monthly information regarding the total number of voting rights and t... December 08, 2014 08:27 ET DBV Technologies S.A. DBV

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+12%
120-day peak, hindsight
Typical move
14%
average across 3 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
DBV712
Phase 3 · Peanut Allergy

Full Press Release Details

Accessibility: Skip TopNav

DBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company Monthly information regarding the total number of voting rights and t...

December 08, 2014 08:27 ET
DBV Technologies S.A.
DBV Technologies S.A.
Monthly information regarding the total number of voting rights and
total number of shares of the Company
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date Total number of shares Total number of voting rights
30/11/2014 18 868 954 Total gross of voting rights: 18 868 954
Total net* of voting rights: 18 861 471
* Total net = total number of voting rights attached to shares - shares without voting rights
Last updated: Dec 8, 2014